Genentech, Samsung Bioepis, Novartis, Biogen face key antitrust hearing July 28
Drugmakers Genentech, Samsung Bioepis, Novartis and Biogen are set to appear before Italian antitrust officials on July 28 for their final defence against allegations they conspired to delay the launch of biosimilar...To view the full article, register now.
Already a subscriber? Click here to view full article